- Home
- BRTX vs DTSS Comparison
BRTX vs DTSS Comparison
Compare BRTX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- DTSS
- Stock Information
- Founded
- BRTX 1997
- DTSS 2014
- Country
- BRTX United States
- DTSS China
- Employees
- BRTX N/A
- DTSS N/A
- Industry
- BRTX Managed Health Care
- DTSS Computer Software: Prepackaged Software
- Sector
- BRTX Health Care
- DTSS Technology
- Exchange
- BRTX Nasdaq
- DTSS Nasdaq
- Market Cap
- BRTX 12.2M
- DTSS 14.2M
- IPO Year
- BRTX N/A
- DTSS N/A
- Fundamental
- Price
- BRTX $1.71
- DTSS $2.13
- Analyst Decision
- BRTX Strong Buy
- DTSS
- Analyst Count
- BRTX 1
- DTSS 0
- Target Price
- BRTX $18.00
- DTSS N/A
- AVG Volume (30 Days)
- BRTX 34.3K
- DTSS 53.5K
- Earning Date
- BRTX 05-13-2025
- DTSS 05-12-2025
- Dividend Yield
- BRTX N/A
- DTSS N/A
- EPS Growth
- BRTX N/A
- DTSS N/A
- EPS
- BRTX N/A
- DTSS N/A
- Revenue
- BRTX $401,000.00
- DTSS $47,284,153.00
- Revenue This Year
- BRTX $446.88
- DTSS N/A
- Revenue Next Year
- BRTX $39.53
- DTSS N/A
- P/E Ratio
- BRTX N/A
- DTSS N/A
- Revenue Growth
- BRTX 175.03
- DTSS 117.51
- 52 Week Low
- BRTX $1.03
- DTSS $1.63
- 52 Week High
- BRTX $2.55
- DTSS $8.56
- Technical
- Relative Strength Index (RSI)
- BRTX 46.37
- DTSS 55.94
- Support Level
- BRTX $1.64
- DTSS $1.84
- Resistance Level
- BRTX $1.78
- DTSS $2.27
- Average True Range (ATR)
- BRTX 0.10
- DTSS 0.15
- MACD
- BRTX -0.01
- DTSS 0.03
- Stochastic Oscillator
- BRTX 42.82
- DTSS 78.13
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.